Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Terminated 1Completed 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Stomach Neoplasms 3Pancreatic Neoplasms 3Gastrointestinal Neoplasms 2Esophageal Neoplasms 2Colorectal Neoplasms 2Postoperative Complications 1Neoplasms 1Frailty 1Colonic Neoplasms 1Carcinoma, Hepatocellular 1

Interventions

Oxaliplatin 29Fluorouracil 25Leucovorin 20Capecitabine 18Irinotecan 17Surveys and Questionnaires 16Bevacizumab 14Cisplatin 12Blood Specimen Collection 11Drug Therapy 10Standard of Care 9Nivolumab 9Gemcitabine 9Cetuximab 7pembrolizumab 6Specimen Handling 6S 1 (combination) 6Endoscopic Mucosal Resection 6Cyclophosphamide 6atezolizumab 5Sunitinib 5Radiotherapy 5Folfox protocol 5Educational Status 5Docetaxel 5fludarabine 4aldesleukin 4Radiosurgery 4Pemetrexed 4Magnetic Resonance Spectroscopy 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Gastrointestinal Neoplasms × Immunonutrition Diet × Gastrointestinal × Clear all
NCT01023412 2025-12-10

IPOD-3

Société des Produits Nestlé (SPN)

Phase NA Terminated
107 enrolled
Gastrointestinal

Gastrointestinal Neoplasms, Neoplasms

NCT05259488 2022-02-28

Preoperative Immunonutrition in Laparoscopic Total D2 Gastrectomy

University of Rome Tor Vergata

Completed
51 enrolled
Gastrointestinal

Gastrointestinal Neoplasms, Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡